BR0207062A - Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal - Google Patents

Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal

Info

Publication number
BR0207062A
BR0207062A BR0207062-6A BR0207062A BR0207062A BR 0207062 A BR0207062 A BR 0207062A BR 0207062 A BR0207062 A BR 0207062A BR 0207062 A BR0207062 A BR 0207062A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
bronchodilator
antiinflammatory agent
treating
active ingredient
Prior art date
Application number
BR0207062-6A
Other languages
English (en)
Inventor
Mark Sanders
Original Assignee
Innovata Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26245685&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0207062(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0102902.4A external-priority patent/GB0102902D0/en
Priority claimed from GB0109215A external-priority patent/GB0109215D0/en
Application filed by Innovata Biomed Ltd filed Critical Innovata Biomed Ltd
Publication of BR0207062A publication Critical patent/BR0207062A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Abstract

"COMPOSIçãO FARMACêUTICA BIMODAL, INALADOR PARA Pó SECO, MéTODO DE APLICAçãO DE UMA QUANTIDADE TERAPEUTICAMENTE EFICAZ DE UM INGREDIENTE ATIVO SUBSTANCIALMENTE FINO AOS PULMõES DE UM PACIENTE, MéTODO DE TRATAMENTO DE UM DISTúRBIO RESPIRATóRIO, MéTODO DE TRATAMENTO DE DOENçA PULMONAR OBSTRUTIVA CRÈNICA (COPD), USO DE UM AGENTE ANTIINFLAMATóRIO, USO DE UM BRONCODILATADOR, USO DE UMA MISTURA DE UM AGENTE ANTIINFLAMATóRIO E DE UM BRONCODILATADOR, E, PROCESSO PARA A FABRICAçãO DE UMA COMPOSIçãO FARMACêUTICA BIMODAL". é descrita uma composição farmacêutica bimodal que compreende quantidades eficazes de um primeiro ingrediente ativo que compreende substancialmente uma fração grossa e um segundo ingrediente ativo que compreende substancialmente uma fração fina caracterizada pelo fato de que a fração grossa possui um maior diâmetro aerodinâmico mediano da massa (MMDA) do que a fração fina. é também descrito um método de um método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino ao pulmão de um paciente pela coadministração com um ingrediente ativo substancialmente grosso.
BR0207062-6A 2001-02-06 2002-02-05 Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal BR0207062A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0102902.4A GB0102902D0 (en) 2001-02-06 2001-02-06 Medicaments
GB0109215A GB0109215D0 (en) 2001-04-12 2001-04-12 Medicaments
PCT/GB2002/000480 WO2002062317A2 (en) 2001-02-06 2002-02-05 Bimodal dry powder formulation for inhalation

Publications (1)

Publication Number Publication Date
BR0207062A true BR0207062A (pt) 2004-10-05

Family

ID=26245685

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207062-6A BR0207062A (pt) 2001-02-06 2002-02-05 Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal

Country Status (12)

Country Link
US (3) US20060292085A1 (pt)
EP (1) EP1359902B1 (pt)
JP (1) JP5154732B2 (pt)
AT (1) ATE369121T1 (pt)
BR (1) BR0207062A (pt)
CA (1) CA2435982C (pt)
DE (1) DE60221640T2 (pt)
ES (1) ES2291452T3 (pt)
MX (1) MXPA03007017A (pt)
NO (1) NO20033451L (pt)
PL (1) PL365736A1 (pt)
WO (1) WO2002062317A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962151B1 (en) * 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AU2003293833B2 (en) * 2002-12-12 2009-10-01 Covis Pharma B.V. Combination medicament
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
DK3212212T3 (da) 2014-10-31 2020-12-21 Univ Monash Pulverformulering

Family Cites Families (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas blancharjq
US385626A (en) * 1888-07-03 Farm-gate
US1858735A (en) * 1930-07-03 1932-05-17 Elwin M Goodsell Dispenser for tobacco or granular material
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
LU53824A1 (pt) * 1967-06-06 1969-03-24
JPS4837815B1 (pt) * 1970-09-25 1973-11-14 Yamanouchi Pharma Co Ltd
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
US3876269A (en) * 1973-04-23 1975-04-08 James N Fisher Preprogrammed medication dispenser
US3874381A (en) * 1974-05-28 1975-04-01 Smithkline Corp Dual nozzle intranasal delivery device
US4047635A (en) * 1975-08-28 1977-09-13 Bennett Jr Arthur A Article dispensing apparatus for selectively dispensing articles
SE408265B (sv) * 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
DE2716323C2 (de) * 1977-04-07 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
US4274403A (en) * 1979-08-29 1981-06-23 Struve Roger L Inhaler
ES506585A0 (es) * 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
DE3274065D1 (de) * 1981-07-08 1986-12-11 Draco Ab Powder inhalator
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
US4604847A (en) * 1983-09-14 1986-08-12 Moulding Jr Thomas S Medicine package, method of opening the package, and machine for performing the method
US4534343A (en) * 1984-01-27 1985-08-13 Trutek Research, Inc. Metered dose inhaler
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
JPS63500175A (ja) * 1985-05-22 1988-01-21 リポソ−ム　テクノロジ−，インコ−ポレイテツド リポソ−ム吸入法および吸入システム
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US4635829A (en) * 1985-05-30 1987-01-13 Brittingham Jr Louis W Measured volume dispenser
FR2584604B1 (fr) * 1985-07-15 1988-11-04 Veyron Froment Laboratoire Composition therapeutique constituant une nouvelle forme galenique orale pour ameliorer la cinetique de la biodisponibilite
GR861995B (en) * 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
SE453566B (sv) * 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SE8601351D0 (sv) * 1986-03-24 1986-03-24 Nilsson Sven Erik Styrd administration av fysiologiskt aktiva emnen
US4950365A (en) * 1988-12-22 1990-08-21 Vac-Tec Systems, Inc. Corrosion free hard coated metal substrates
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5007419A (en) * 1989-09-25 1991-04-16 Allan Weinstein Inhaler device
US5002048A (en) * 1989-12-12 1991-03-26 Makiej Jr Walter J Inhalation device utilizing two or more aerosol containers
US5113855A (en) * 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
GB9015522D0 (en) * 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
IT1243344B (it) * 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
DE4027390C2 (de) * 1990-08-30 1994-11-03 Boehringer Ingelheim Kg Treibgasfreies Inhalationsgerät
DE4027391A1 (de) * 1990-08-30 1992-03-12 Boehringer Ingelheim Kg Treibgasfreies inhalationsgeraet
FR2667509B1 (fr) * 1990-10-04 1995-08-25 Valois Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
US5042472A (en) * 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
GB9027234D0 (en) * 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
DE69430303T2 (de) * 1991-03-05 2002-11-28 Aradigm Corp Verfahren und vorrichtung zur korrektur eines nullsignals eines drucksensors fur einen durchflussmesser
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
BR9106690A (pt) * 1991-04-15 1993-06-29 Huhtamaeki Yhthymae Oy Disposicao para medir uma dose de medicamentos pulverulento para inalacao e aparelho de inalacao dotado do mesmo
DE4211475A1 (de) * 1991-12-14 1993-06-17 Asta Medica Ag Pulverinhalator
GB9203761D0 (en) * 1992-02-21 1992-04-08 Innovata Biomed Ltd Inhaler
WO1993025198A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Ultrafine powder for inhalation and production thereof
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
TW223015B (pt) * 1992-07-01 1994-05-01 Duphar Int Res
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
DE4239402A1 (de) * 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
ES2128550T3 (es) * 1992-12-18 1999-05-16 Schering Corp Inhalador para medicamentos en polvo.
US5896855A (en) * 1992-12-24 1999-04-27 Rhone-Poulenc Rorer Limited Multi dose inhaler apparatus
US5411175A (en) * 1993-03-08 1995-05-02 New England Pharmaceuticals, Inc. Cartridges, devices and methods for dispensing liquids
GB9312984D0 (en) * 1993-06-23 1993-08-04 Bespak Plc Atomising dispenser
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5437267A (en) * 1993-08-03 1995-08-01 Weinstein; Allan Device for delivering aerosol to the nasal membranes and method of use
US5524613A (en) * 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
US5450160A (en) * 1993-12-22 1995-09-12 Eastman Kodak Company Film cartridge magazine
US5415162A (en) * 1994-01-18 1995-05-16 Glaxo Inc. Multi-dose dry powder inhalation device
US5664557A (en) * 1994-03-10 1997-09-09 Respiratory Delivery Systems, Inc. Releasably engageable coupling for an inhaler
FI942196A (fi) * 1994-05-11 1995-11-12 Orion Yhtymae Oy Jauheinhalaattori
US5562231A (en) * 1994-07-29 1996-10-08 Ortho Pharmaceutical Corporation Variable day start tablet dispenser
US5775536A (en) * 1994-07-29 1998-07-07 Ortho Pharmaceutical Corp. Variable day start tablet dispenser
WO1996008284A2 (en) * 1994-09-16 1996-03-21 Laboratoire Glaxo Wellcome Inhalation device
DE59408619D1 (de) * 1994-10-07 1999-09-16 Rueti Ag Maschf Wagen zum Wechseln des Webgeschirrs einer Webmaschine
US5485939A (en) * 1994-11-09 1996-01-23 Tucker; Gary D. Lollipop dispenser apparatus
SE9404140D0 (sv) * 1994-11-29 1994-11-29 Astra Ab Dose indicating device
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
US5921237A (en) * 1995-04-24 1999-07-13 Dura Pharmaceuticals, Inc. Dry powder inhaler
AU128811S (en) * 1995-06-06 1996-12-03 Orion Yhtymae Oy A protective cover for example a moisture protective cover for a powder inhaler
SE504458C2 (sv) * 1995-06-21 1997-02-17 Lars Gunnar Nilsson Inhalator för elektrisk dosering av substanser
DE19523516C1 (de) * 1995-06-30 1996-10-31 Asta Medica Ag Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
US5664697B1 (en) * 1995-10-31 1998-09-15 Ortho Pharma Corp Automatically advancing pill regimen device
CN1213974A (zh) * 1996-01-03 1999-04-14 葛兰素集团有限公司 吸入器具
BR9707660A (pt) * 1996-02-21 2001-10-30 Schering Corp Inalador de medicação em pó
US5875776A (en) * 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
US6254854B1 (en) * 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
JPH09331451A (ja) * 1996-06-11 1997-12-22 Mita Ind Co Ltd 画像読取装置
GB9626263D0 (en) * 1996-12-18 1997-02-05 Innovata Biomed Ltd Powder inhaler
GB9626233D0 (en) * 1996-12-18 1997-02-05 Chawla Brinda P S Medicament packaging and deliveery device
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700424D0 (sv) * 1997-02-07 1997-02-07 Astra Ab Powder inhaler
US6006747A (en) * 1997-03-20 1999-12-28 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5904139A (en) * 1997-03-28 1999-05-18 Hauser; Stephen G. Breath coordinated inhaler
US5941241A (en) * 1997-05-12 1999-08-24 Weinstein; Robert E. Method and device for organizing and coordinating the combined use of topical aerosols for the treatment of respiratory disorders
US5944660A (en) * 1997-07-08 1999-08-31 Optical Sensors Incorporated Disposable cartridge assembly with optional integrated temperature control system, and systems containing same
CA2212430A1 (en) * 1997-08-07 1999-02-07 George Volgyesi Inhalation device
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
GB9722285D0 (en) * 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6116238A (en) * 1997-12-02 2000-09-12 Dura Pharmaceuticals, Inc. Dry powder inhaler
EP1044029B1 (en) * 1998-01-03 2003-10-08 Innovata Biomed Limited Filling method
DE19803524A1 (de) * 1998-01-30 1999-08-05 Grohe Armaturen Friedrich Betätigungseinrichtung für ein Wasserventil
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6234167B1 (en) * 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
GB9827200D0 (en) * 1998-12-11 1999-02-03 Glaxo Group Ltd Dry powder inhaler
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
US6196218B1 (en) * 1999-02-24 2001-03-06 Ponwell Enterprises Ltd Piezo inhaler
US6601729B1 (en) * 1999-03-26 2003-08-05 Papp Enterprises, Llc Automated portable medication radial dispensing apparatus and method using a carrier tape
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
GB9928265D0 (en) * 1999-12-01 2000-01-26 Innovata Biomed Ltd Inhaler
ATE296654T1 (de) * 1999-12-07 2005-06-15 Orion Corp Mehrfachpulverinhalator
GB0016478D0 (en) * 2000-07-05 2000-08-23 Innovata Biomed Ltd Valve
US6543443B1 (en) * 2000-07-12 2003-04-08 Aerogen, Inc. Methods and devices for nebulizing fluids
GB0102902D0 (en) * 2001-02-06 2001-03-21 Innovata Biomed Ltd Medicaments
US6523536B2 (en) * 2001-03-12 2003-02-25 Birdsong Medical Devices, Inc. Dual-canister inhaler having a spacer and easy to operate lever mechanism
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
GB0128148D0 (en) * 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US20040101782A1 (en) * 2002-11-27 2004-05-27 General Electric Company Method for making optical device structures

Also Published As

Publication number Publication date
JP2004523536A (ja) 2004-08-05
WO2002062317A2 (en) 2002-08-15
NO20033451D0 (no) 2003-08-04
WO2002062317A3 (en) 2002-11-21
MXPA03007017A (es) 2004-09-13
CA2435982C (en) 2014-05-06
JP5154732B2 (ja) 2013-02-27
US20100136121A1 (en) 2010-06-03
ES2291452T3 (es) 2008-03-01
EP1359902B1 (en) 2007-08-08
US20060292085A1 (en) 2006-12-28
ATE369121T1 (de) 2007-08-15
PL365736A1 (en) 2005-01-10
CA2435982A1 (en) 2002-08-15
NO20033451L (no) 2003-10-03
DE60221640T2 (de) 2008-05-21
DE60221640D1 (de) 2007-09-20
EP1359902A2 (en) 2003-11-12
US20140342001A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
EP3494995A3 (en) Formoterol superfine formulation
PT1326595E (pt) Composicao farmaceutica compreendendo resveratrol para o tratamento de disturbios respiratorios inflamatorios
WO2005079755A3 (en) Interleukin-13 antagonist powders, spray-dried particles, and methods
BR9812693A (pt) Uso de um agente bioativo, processo para formar uma microestrutura perfurada, microestrutura perfurada, processo para aumentar a dispersibilidade de um pó, pó de microestrutura perfurada, pó tendo dispersibilidade aumentada, sistema de inalação para a administração pulmonar de um agente bioativo a um paciente, e, processo para a liberação pulmonar de um ou mais agentes bioativos
IS4179A (is) Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
HUP0300499A2 (en) Pharmaceutical formulations for dry powder inhalers
BR0107304A (pt) Pó para inalação contendo tiotrópio
RU2006132036A (ru) Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей
FI20002215A0 (fi) Yhdistelmäpartikkelit
BR9307141A (pt) Processo para a liberação sistência pulsátil de um fragmento ativo de hormônio de paratiróide (PTH) para um hospedeiro mamífero e para um paciente e composição farmacêutica
CA2405705A1 (en) The treatment of respiratory diseases
CA2389349A1 (en) Aerosol composition comprising formoterol
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
WO2007109118A3 (en) RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
WO2021242776A3 (en) Methods of treating inflammatory diseases by blocking galectin-3
BR0207062A (pt) Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
JP2002509119A (ja) ドーパミン（Ｄ２）レセプターアゴニスト活性を有する化合物およびβ２−アドレナリンレセプターアゴニスト活性を有する化合物（Ｂ）を含有する薬学的組成物
CA2499273A1 (en) Inhalation compositions
RU2338552C2 (ru) Фармацевтическая композиция для ингаляции
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof
JP2004523536A5 (pt)
Prokopovich History of inhaler devices
JP6021952B2 (ja) 慢性閉塞性肺疾患の治療法
JP2007506768A5 (pt)
Schlesinger Disposition of inhaled particles and gases

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]